University of Dundee - Confidence in Concept 2014

Lead Research Organisation: University of Dundee


Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.
Description European Lead Factory
Amount £500,000 (GBP)
Organisation European Commission 
Department Innovative Medicines Initiative (IMI)
Sector Public
Country Belgium
Start 05/2017 
Description High growth spinout
Amount £131,000 (GBP)
Organisation Scottish Enterprise 
Sector Public
Country United Kingdom
Start 08/2020 
End 03/2021
Description MRC
Amount £823,000 (GBP)
Funding ID MR/P000509/1 
Organisation Medical Research Council (MRC) 
Sector Public
Country United Kingdom
Description project grant
Amount £261,067 (GBP)
Organisation Arch Therapeutics 
Sector Private
Country United States
Start 01/2017 
End 12/2019
Description project grant
Amount £209,048 (GBP)
Organisation Versus Arthritis 
Sector Charity/Non Profit
Country United Kingdom
Start 01/2014 
End 12/2016
Description translational medical research fund 2014
Amount £18,500 (GBP)
Organisation University of Dundee 
Sector Academic/University
Country United Kingdom
Start 03/2014 
Description Hit TB TbCoABC sub-project 
Organisation Foundation for the National Institutes of Health (FNIH)
Country United States 
Sector Charity/Non Profit 
PI Contribution Data and assays generated by the CiC supported HTS project. The hit Tb grant (our funded resource from the collaboration) we will support 1 FTE years chemistry and computational chemistry plus purchasing of commercial analogues of the hits.
Collaborator Contribution Structural biology Tb cell biology and animal model work on selected examples. Fragment screening data and assays.
Impact To early to generate defined outputs
Start Year 2015
Description Investment Partnership Agreement 
Organisation Perceptive Bioscience Holdings Ltd
Country United Kingdom 
Sector Academic/University 
PI Contribution The University has signed an Investment Partnership Agreement with Perceptive that will allow the DDU to further translate programmes developed with MRC CiC funding up to preclinical candidates.
Collaborator Contribution Perceptive will underwrite the CURE Fund for up to 10 years.
Impact The investment sum will be disclosed later in the year.
Start Year 2016